WallStreetZenWallStreetZen

NYSE: NGVT
Ingevity Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their NGVT stock forecasts and price targets.

Forecast return on equity

Is NGVT forecast to generate an efficient return?

Company
509.53%
Industry
31.09%
Market
149.47%
NGVT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NGVT forecast to generate an efficient return on assets?

Company
15.54%
Industry
9.99%
NGVT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NGVT earnings per share forecast

What is NGVT's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$5.47+246.03%
Avg 2 year Forecast
$6.17+290.35%
Avg 3 year Forecast
$6.95+339.96%
NGVT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

NGVT revenue forecast

What is NGVT's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$1.1B-2.09%
Avg 2 year Forecast
$1.2B-0.72%
Avg 3 year Forecast
$1.2B+1.35%
NGVT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NGVT earnings growth forecast

How is NGVT forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
98%
Industry
32.9%
Market
63.22%
NGVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
NGVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
NGVT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

NGVT revenue growth forecast

How is NGVT forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
-0.25%
Industry
4.82%
Market
15.04%
NGVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NGVT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NGVT vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
NGVT$68.10N/AN/A
IOSP$93.57N/AN/A
CC$15.04$20.43+35.83%Buy
MTX$69.22$90.00+30.02%Strong Buy
HWKN$125.35$171.00+36.42%Buy
View Top Specialty Chemical Stocks

Ingevity Stock Forecast FAQ

What is NGVT's earnings growth forecast for 2026-2028?

(NYSE: NGVT) Ingevity's forecast annual earnings growth rate of 98% is forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 32.9%, and it is also forecast to beat the US market's average forecast earnings growth rate of 63.22%.

Ingevity's earnings in 2026 is $54,000,000.On average, 5 Wall Street analysts forecast NGVT's earnings for 2026 to be $187,950,975, with the lowest NGVT earnings forecast at $173,505,372, and the highest NGVT earnings forecast at $199,615,404. On average, 5 Wall Street analysts forecast NGVT's earnings for 2027 to be $212,029,272, with the lowest NGVT earnings forecast at $198,773,145, and the highest NGVT earnings forecast at $223,439,304.

In 2028, NGVT is forecast to generate $238,971,249 in earnings, with the lowest earnings forecast at $218,987,363 and the highest earnings forecast at $257,370,313.

If you're new to stock investing, here's how to buy Ingevity stock.

What is NGVT's revenue growth forecast for 2026-2028?

(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of -0.25% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.04%.

Ingevity's revenue in 2026 is $1,160,300,000.On average, 5 Wall Street analysts forecast NGVT's revenue for 2026 to be $39,053,319,392, with the lowest NGVT revenue forecast at $37,231,289,526, and the highest NGVT revenue forecast at $40,600,325,882. On average, 5 Wall Street analysts forecast NGVT's revenue for 2027 to be $39,603,366,144, with the lowest NGVT revenue forecast at $37,265,667,448, and the highest NGVT revenue forecast at $41,700,419,386.

In 2028, NGVT is forecast to generate $40,428,436,272 in revenue, with the lowest revenue forecast at $38,743,918,094 and the highest revenue forecast at $41,734,797,308.

What is NGVT's forecast return on assets (ROA) for 2026-2028?

(NYSE: NGVT) forecast ROA is 15.54%, which is higher than the forecast US Specialty Chemicals industry average of 9.99%.

What is NGVT's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: NGVT) Ingevity's current Earnings Per Share (EPS) is $1.58. On average, analysts forecast that NGVT's EPS will be $5.47 for 2026, with the lowest EPS forecast at $5.05, and the highest EPS forecast at $5.81. On average, analysts forecast that NGVT's EPS will be $6.17 for 2027, with the lowest EPS forecast at $5.78, and the highest EPS forecast at $6.50. In 2028, NGVT's EPS is forecast to hit $6.95 (min: $6.37, max: $7.49).

What is NGVT's forecast return on equity (ROE) for 2026-2028?

(NYSE: NGVT) forecast ROE is 509.53%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.